GODAVARIB — Godavari Biorefineries Share News
0.000.00%
Last trade - 00:00- IN₹12.10bn
- IN₹17.26bn
- IN₹19.88bn
Brief: Godavari Biorefineries Says US Patent Granted For Cancer Treatment Compound
Brief: Godavari Biorefineries Says Mexican Patent Office Grants Patent For Compounds Treating Viral Infections
India's Godavari Biorefineries jumps after securing Chinese patent
Brief: Godavari Biorefineries Says Chinese Patent Office Grants Patent For Use Of Compounds To Treat Viral Infections
India's Godavari Biorefineries jumps on European patent
Brief: Godavari Biorefineries Granted European Patent For Pharmaceutical Composition
Brief: Godavari Biorefineries Commences Corn/Grain-Based Distillery At Sameerwadi Unit
Brief: Godavari Biorefineries Gets Japanese Patent For Cancer Treatment Compound
India's Godavari Biorefineries jumps on getting patent for cancer treatment compound
Brief: Godavari Biorefineries Gets Japanese Patent For Treating Viral Infections
India's Godavari Biorefineries to start grain-based distillery in June quarter
Brief: Godavari Biorefineries Dec-Quarter Consol PAT 82.5 Million Rupees
Brief: Godavari Biorefineries Partners With Synthomer To Develop Bio-Based Alternatives To Fossil-Based Monomers
Brief: Godavari Biorefineries Says Sathgen Therapeutics Division Expands To U.S. With Launch Of Subsidiary
Brief: Godavari Biorefineries Granted US Patent For Anti-Cancer Compounds
Brief: Godavari Biorefineries European Patent Granted For Inhibition Of Unregulated Cell Growth
India's Godavari Biorefineries hits upper circuit on Chinese patent for cancer drug
Brief: Godavari Biorefineries Secures Chinese Patent For Anti-Cancer Molecule
India's Godavari Biorefineries rises after getting patent approval